Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Hosaka

Showing results (61-70 of 306) with videos related to

Pageof 31
Sort By:
Journal of Medical Virology|September 15, 2007
Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1bNorio Akuta, Fumitaka Suzuki, Yusuke Kawamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 1, 2013
Magnetic resonance laparoscopy: A new non-invasive technique for the assessment of chronic viral liver diseaseSuguru Ogura, Satoshi Saitoh, Yusuke Kawamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 4, 2013
Randomized controlled trial of a new procedure of radiofrequency ablation using an expandable needle for hepatocellular carcinomaMiharu Hirakawa, Kenji Ikeda, Masahiro Kobayashi, et al.
Journal of Clinical Microbiology|July 3, 2015
Impact of Mutations at Amino Acid 70 in Hepatitis C Virus (HCV) Genotype 1b Core Region on Hepatocarcinogenesis following Eradication of HCV RNANorio Akuta, Fumitaka Suzuki, Masahiro Kobayashi, et al.
Journal of Medical Virology|August 18, 2016
Sustained virologic response by direct antiviral agents reduces the incidence of hepatocellular carcinoma in patients with HCV infectionMasahiro Kobayashi, Fumitaka Suzuki, Shunichiro Fujiyama, et al.
Journal of Hepatology|November 28, 2006
Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholesterol levelsNorio Akuta, Fumitaka Suzuki, Yusuke Kawamura, et al.
Journal of Gastroenterology|June 27, 2006
Efficacy of interferon monotherapy in young adult patients with chronic hepatitis C virus infectionKiminori Uka, Fumitaka Suzuki, Norio Akuta, et al.
Journal of Medical Virology|June 29, 2007
Prolonged-interferon therapy reduces hepatocarcinogenesis in aged-patients with chronic hepatitis CYasuji Arase, Kenji Ikeda, Fumitaka Suzuki, et al.
Journal of Medical Virology|February 17, 2005
Favorable efficacy of long-term lamivudine therapy in patients with chronic hepatitis B: an 8-year follow-up studyNorio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, et al.
Journal of Gastroenterology|June 4, 2004
Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapyYasuji Arase, Kenji Ikeda, Akihito Tsubota, et al.
Pageof 31

Showing results (61-70 of 306) with videos related to

Sort By:
Pageof 31
Journal of Medical Virology|September 15, 2007
Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1bNorio Akuta, Fumitaka Suzuki, Yusuke Kawamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 1, 2013
Magnetic resonance laparoscopy: A new non-invasive technique for the assessment of chronic viral liver diseaseSuguru Ogura, Satoshi Saitoh, Yusuke Kawamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 4, 2013
Randomized controlled trial of a new procedure of radiofrequency ablation using an expandable needle for hepatocellular carcinomaMiharu Hirakawa, Kenji Ikeda, Masahiro Kobayashi, et al.
Journal of Clinical Microbiology|July 3, 2015
Impact of Mutations at Amino Acid 70 in Hepatitis C Virus (HCV) Genotype 1b Core Region on Hepatocarcinogenesis following Eradication of HCV RNANorio Akuta, Fumitaka Suzuki, Masahiro Kobayashi, et al.
Journal of Medical Virology|August 18, 2016
Sustained virologic response by direct antiviral agents reduces the incidence of hepatocellular carcinoma in patients with HCV infectionMasahiro Kobayashi, Fumitaka Suzuki, Shunichiro Fujiyama, et al.
Journal of Hepatology|November 28, 2006
Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholesterol levelsNorio Akuta, Fumitaka Suzuki, Yusuke Kawamura, et al.
Journal of Gastroenterology|June 27, 2006
Efficacy of interferon monotherapy in young adult patients with chronic hepatitis C virus infectionKiminori Uka, Fumitaka Suzuki, Norio Akuta, et al.
Journal of Medical Virology|June 29, 2007
Prolonged-interferon therapy reduces hepatocarcinogenesis in aged-patients with chronic hepatitis CYasuji Arase, Kenji Ikeda, Fumitaka Suzuki, et al.
Journal of Medical Virology|February 17, 2005
Favorable efficacy of long-term lamivudine therapy in patients with chronic hepatitis B: an 8-year follow-up studyNorio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, et al.
Journal of Gastroenterology|June 4, 2004
Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapyYasuji Arase, Kenji Ikeda, Akihito Tsubota, et al.
Pageof 31